Marc Peschanski
Overview
Explore the profile of Marc Peschanski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
2572
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Martinat C, Peschanski M
Med Sci (Paris)
. 2019 Jan;
34(12):1019-1021.
PMID: 30623755
No abstract available.
12.
Bassez G, Audureau E, Peschanski M
Brain
. 2019 Jan;
142(2):e6.
PMID: 30615109
No abstract available.
13.
Bassez G, Audureau E, Hogrel J, Arrouasse R, Baghdoyan S, Bhugaloo H, et al.
Brain
. 2018 Sep;
141(10):2855-2865.
PMID: 30169600
Metformin, the well-known anti-diabetic drug, has been shown recently to improve the grip test performance of the DMSXL mouse model of myotonic dystrophy type 1. The drug may have positively...
14.
Ben MBarek K, Habeler W, Plancheron A, Jarraya M, Regent F, Terray A, et al.
Sci Transl Med
. 2017 Dec;
9(421).
PMID: 29263231
Replacing defective retinal pigment epithelial (RPE) cells with those derived from human embryonic stem cells (hESCs) or human-induced pluripotent stem cells (hiPSCs) is a potential strategy for treating retinal degenerative...
15.
Domingues S, Masson Y, Marteyn A, Allouche J, Perrier A, Peschanski M, et al.
Stem Cell Res Ther
. 2017 Dec;
8(1):285.
PMID: 29258610
Background: Epidermal grafting using cells derived from pluripotent stem cells will change the face of this side of regenerative cutaneous medicine. To date, the safety of the graft would be...
16.
Egesipe A, Blondel S, Lo Cicero A, Jaskowiak A, Navarro C, De Sandre-Giovannoli A, et al.
NPJ Aging Mech Dis
. 2017 Jul;
2:16026.
PMID: 28721276
Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder that causes systemic accelerated aging in children. This syndrome is due to a mutation in the gene that leads to the...
17.
Seidel D, Obendorf J, Englich B, Jahnke H, Semkova V, Haupt S, et al.
Biosens Bioelectron
. 2016 Jul;
86:277-286.
PMID: 27387257
In today's neurodevelopment and -disease research, human neural stem/progenitor cell-derived networks represent the sole accessible in vitro model possessing a primary phenotype. However, cultivation and moreover, differentiation as well as...
18.
Darville H, Poulet A, Rodet-Amsellem F, Chatrousse L, Pernelle J, Boissart C, et al.
EBioMedicine
. 2016 Jun;
9:293-305.
PMID: 27333044
Autism spectrum disorders affect millions of individuals worldwide, but their heterogeneity complicates therapeutic intervention that is essentially symptomatic. A versatile yet relevant model to rationally screen among hundreds of therapeutic...
19.
Rolland M, Li X, Sellier Y, Martin H, Perez-Berezo T, Rauwel B, et al.
PLoS Pathog
. 2016 Apr;
12(4):e1005547.
PMID: 27078877
Congenital infection by human cytomegalovirus (HCMV) is a leading cause of permanent sequelae of the central nervous system, including sensorineural deafness, cerebral palsies or devastating neurodevelopmental abnormalities (0.1% of all...
20.
Massourides E, Polentes J, Mangeot P, Mournetas V, Nectoux J, Deburgrave N, et al.
Skelet Muscle
. 2015 Nov;
5:40.
PMID: 26568816
Background: Duchenne muscular dystrophy (DMD) is a devastating X-linked recessive genetic myopathy. DMD physiopathology is still not fully understood and a prenatal onset is suspected but difficult to address. Methods:...